Skip to main content
Cash
Portfolio
TrendingMidtermsElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentionsFinanceTech & Science
PredictLive133AccountSocial
MARKETSINVESTLIVE133
Product
Kalshi ProInvestMarketsIncentive programSmall business hedgingInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQPrediction marketsFee scheduleTrading hoursRegulatoryTrust Center

© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
Series Image
  1. Health & science

When will CMS announce the addition of GLP-1 drugs for obesity to Part D?

Excludes the Medicare GLP-1 Bridge


Chance

6%

6%

36%

36%

46%

46%

When will CMS announce the addition of GLP-1 drugs for obesity to Part D?

Before Jan 1, 2027

Odds
6% chance
Max payout
Dec 31, 2026
$0
$21,837 vol
More Politics Markets

Trending Politics markets

Who will be Trump's next Press Secretary?Who will leave their role in the Trump administration this year?What caused the FAA's nationwide ground stop?Who will officially lead Venezuela at the end of 2026?Howard Lutnick out as Commerce Secretary?Traffic through the Strait of Hormuz? (11/9 - 11/15)Pete Hegseth out as Secretary of Defense?Traffic through the Bab el-Mandeb Strait? (11/9 - 11/15)

Politics hub

All Politics markets